Credit Suisse’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-11,657
| Closed | -$123K | – | 3207 |
|
|
2023
Q1 | $123K | Buy |
11,657
+2
| +0% | +$21 | ﹤0.01% | 3171 |
|
|
2022
Q4 | $395K | Buy |
11,655
+134
| +1% | +$4.54K | ﹤0.01% | 2900 |
|
|
2022
Q3 | $553K | Sell |
11,521
-319
| -3% | -$15.3K | ﹤0.01% | 2710 |
|
|
2022
Q2 | $674K | Sell |
11,840
-1,928
| -14% | -$110K | ﹤0.01% | 2635 |
|
|
2022
Q1 | $1.11M | Buy |
13,768
+3,001
| +28% | +$242K | ﹤0.01% | 2463 |
|
|
2021
Q4 | $2.18M | Sell |
10,767
-1,658
| -13% | -$336K | ﹤0.01% | 2096 |
|
|
2021
Q3 | $3.35M | Buy |
12,425
+834
| +7% | +$225K | ﹤0.01% | 1789 |
|
|
2021
Q2 | $2.98M | Sell |
11,591
-2,411
| -17% | -$620K | ﹤0.01% | 1903 |
|
|
2021
Q1 | $4.2M | Sell |
14,002
-2,064
| -13% | -$619K | ﹤0.01% | 1656 |
|
|
2020
Q4 | $4.1M | Sell |
16,066
-38,557
| -71% | -$9.83M | ﹤0.01% | 1664 |
|
|
2020
Q3 | $13.6M | Sell |
54,623
-10,316
| -16% | -$2.57M | 0.01% | 873 |
|
|
2020
Q2 | $22.6M | Sell |
64,939
-15,409
| -19% | -$5.35M | 0.02% | 688 |
|
|
2020
Q1 | $21.5M | Buy |
80,348
+35,472
| +79% | +$9.5M | 0.02% | 645 |
|
|
2019
Q4 | $14.5M | Sell |
44,876
-8,185
| -15% | -$2.65M | 0.01% | 914 |
|
|
2019
Q3 | $14.5M | Buy |
53,061
+15,043
| +40% | +$4.11M | 0.01% | 833 |
|
|
2019
Q2 | $20.3M | Buy |
38,018
+6,414
| +20% | +$3.42M | 0.02% | 705 |
|
|
2019
Q1 | $15.9M | Sell |
31,604
-33
| -0.1% | -$16.6K | 0.01% | 764 |
|
|
2018
Q4 | $15.6M | Sell |
31,637
-1,215
| -4% | -$599K | 0.02% | 748 |
|
|
2018
Q3 | $30M | Buy |
32,852
+2,266
| +7% | +$2.07M | 0.03% | 549 |
|
|
2018
Q2 | $22.4M | Buy |
30,586
+4,454
| +17% | +$3.26M | 0.02% | 653 |
|
|
2018
Q1 | $41.7M | Buy |
26,132
+3,613
| +16% | +$5.76M | 0.04% | 414 |
|
|
2017
Q4 | $20.2M | Sell |
22,519
-1,915
| -8% | -$1.72M | 0.02% | 702 |
|
|
2017
Q3 | $8.8M | Buy |
24,434
+4,824
| +25% | +$1.74M | 0.01% | 1078 |
|
|
2017
Q2 | $5.75M | Sell |
19,610
-3,454
| -15% | -$1.01M | 0.01% | 1295 |
|
|
2017
Q1 | $8.12M | Sell |
23,064
-12,324
| -35% | -$4.34M | 0.01% | 1137 |
|
|
2016
Q4 | $6.51M | Buy |
35,388
+2,069
| +6% | +$381K | 0.01% | 1263 |
|
|
2016
Q3 | $8.59M | Buy |
33,319
+976
| +3% | +$252K | 0.01% | 1135 |
|
|
2016
Q2 | $6.9M | Buy |
32,343
+6,204
| +24% | +$1.32M | 0.01% | 1253 |
|
|
2016
Q1 | $5.39M | Sell |
26,139
-1,071
| -4% | -$221K | 0.01% | 1320 |
|
|
2015
Q4 | $6.88M | Sell |
27,210
-532
| -2% | -$134K | 0.01% | 1269 |
|
|
2015
Q3 | $4.56M | Sell |
27,742
-16,363
| -37% | -$2.69M | 0.01% | 1525 |
|
|
2015
Q2 | $8.28M | Buy |
44,105
+13,672
| +45% | +$2.57M | 0.01% | 1254 |
|
|
2015
Q1 | $5.02M | Sell |
30,433
-3,695
| -11% | -$610K | 0.01% | 1496 |
|
|
2014
Q4 | $7.94M | Buy |
34,128
+8,613
| +34% | +$2M | 0.01% | 1234 |
|
|
2014
Q3 | $4.62M | Buy |
25,515
+5,794
| +29% | +$1.05M | ﹤0.01% | 1558 |
|
|
2014
Q2 | $3.79M | Buy |
19,721
+1,931
| +11% | +$371K | ﹤0.01% | 1885 |
|
|
2014
Q1 | $3.23M | Sell |
17,790
-452
| -2% | -$82.1K | ﹤0.01% | 1861 |
|
|
2013
Q4 | $3.11M | Buy |
18,242
+5,402
| +42% | +$919K | ﹤0.01% | 1940 |
|
|
2013
Q3 | $2.01M | Sell |
12,840
-16,413
| -56% | -$2.57M | ﹤0.01% | 2040 |
|
|
2013
Q2 | $5.07M | Buy |
+29,253
| New | +$5.07M | 0.01% | 1317 |
|